References
- Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br. J. Cancer 74(10), 1511–1513 (1996).
- Kiire CA, Srinivasan S, Karp CL. Ocular surface squamous neoplasia. Int. Ophthalmol. Clin. 50(3), 35–46 (2010).
- Gaasterland DE, Rodrigues MM, Moshell AN. Ocular involvement in xeroderma pigmentosum. Ophthalmology 89(8), 980–986 (1982).
- Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br. J. Ophthalmol. 80(6), 503–508 (1996).
- Karp CL, Scott IU, Chang TS, Pflugfelder SC. Conjunctival intraepithelial neoplasia. A possible marker for human immunodeficiency virus infection? Arch. Ophthalmol. 114(3), 257–261 (1996).
- Newton R, Ferlay J, Reeves G, Beral V, Parkin DM. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 347(9013), 1450–1451 (1996).
- Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 345(8951), 695–696 (1995).
- Pe’er J, Frucht-Pery J. Ocular surface squamous neoplasia. In: Clinical Ophthalmic Oncology. Singh AD, Pe’er J, Murphree AL (Eds). Elsevier, PA, USA, 136 (2007).
- Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 92(6), 728–733 (1985).
- Nolan GR, Hirst LW, Wright RG, Bancroft BJ. Application of impression cytology to the diagnosis of conjunctival neoplasms. Diagn. Cytopathol. 11(3), 246–249 (1994).
- Lee GA, Williams G, Hirst LW, Green AC. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101(2), 360–364 (1994).
- Gelender H, Forster RK. Papanicolaou cytology in the diagnosis and management of external ocular tumors. Arch. Ophthalmol. 98(5), 909–912 (1980).
- Xu Y, Zhou Z, Xu Y et al. The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye (Lond.) 26(6), 781–787 (2012).
- Hassani RT, Brasnu E, Amar N et al. Contribution of in vivo confocal microscopy to diagnosis of invasive ocular surface squamous neoplasia: a case report. J. Fr. Ophtalmol. 33(3), 163–168 (2010).
- Duchateau N, Hugol D, D’Hermies F et al. Contribution of in vivo confocal microscopy to limbal tumor evaluation. J. Fr. Ophtalmol. 28(8), 810–816 (2005).
- Kieval JZ, Karp CL, Abou Shousha M et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology 119(3), 481–486 (2012).
- Chevaliez S, Pawlotsky JM. Interferon-based therapy of hepatitis C. Adv. Drug Deliv. Rev. 59(12), 1222–1241 (2007).
- Chakalova G, Ganchev G. Local administration of interferon-α in cases of cervical intraepithelial neoplasia associated with human papillomavirus infection. J. BUON 9(4), 399–402 (2004).
- Edwards L, Berman B, Rapini RP et al. Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. Arch. Dermatol. 128(11), 1486–1489 (1992).
- Boehm JS, Hahn WC. Immortalized cells as experimental models to study cancer. Cytotechnology 45(1–2), 47–59 (2004).
- Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 106(1), 91–97 (1999).
- Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon α-2b. Ophthalmology 108(6), 1093–1098 (2001).
- Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon α-2b. Cornea 21(1), 6–11 (2002).
- Sepulveda R, Pe’er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br. J. Ophthalmol. 94(5), 532–535 (2010).
- Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin. Ophthalmol. 2(3), 503–515 (2008).
- Cornell RC, Greenway HT, Tucker SB et al. Intralesional interferon therapy for basal cell carcinoma. J. Am. Acad. Dermatol. 23(4 Pt 1), 694–700 (1990).
- Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon α 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br. J. Ophthalmol. 94(5), 551–554 (2010).
- Sturges A, Butt AL, Lai JE, Chodosh J. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 115(8), 1297.e1–1302.e1 (2008).
- Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE. Giant ocular surface squamous neoplasia managed with interferon α-2b as immunotherapy or immunoreduction. Ophthalmology 119(5), 938–944 (2012).
- Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon a2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology 117(12), 2241–2246 (2010).
- Verweij J, Pinedo HM. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer. Drugs 1(1), 5–13 (1990).
- Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs 66(3), 321–340 (2006).
- Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon’s capsule fibroblasts. Ophthalmology 99(9), 1471–1476 (1992).
- Derick RJ, Pasquale L, Quigley HA, Jampel H. Potential toxicity of mitomycin C. Arch. Ophthalmol. 109(12), 1635 (1991).
- Prabhasawat P, Tseng SC. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch. Ophthalmol. 115(11), 1360–1367 (1997).
- Frucht-Pery J, Sugar J, Baum J et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 104(12), 2085–2093 (1997).
- Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am. J. Ophthalmol. 124(3), 303–311 (1997).
- Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with mitomycin C. Br. J. Ophthalmol. 94(5), 555–558 (2010).
- Georgopoulos M, Vass C, Vatanparast Z. Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. Curr. Eye Res. 25(4), 221–225 (2002).
- Quebbeman EJ, Hoffman NE, Ausman RK, Hamid AA. Stability of mitomycin admixtures. Am. J. Hosp. Pharm. 42(8), 1750–1754 (1985).
- Khong JJ, Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br. J. Ophthalmol. 90(7), 819–822 (2006).
- Russell HC, Chadha V, Lockington D, Kemp EG. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br. J. Ophthalmol. 94(10), 1316–1321 (2010).
- Billing K, Karagiannis A, Selva D. Punctal–canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am. J. Ophthalmol. 136(4), 746–747 (2003).
- Kubota T. 5-fluorouracil and dihydropyrimidine dehydrogenase. Int. J. Clin. Oncol. 8(3), 127–131 (2003).
- Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA. 5-fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 107(12), 2190–2195 (2000).
- Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br. J. Ophthalmol. 84(3), 268–272 (2000).
- Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Semin. Ophthalmol. 21(3), 161–169 (2006).
- de Keizer RJ, de Wolff-Rouendaal D, van Delft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc. Ophthalmol. 64(1), 31–42 (1986).
- Midena E, Boccato P, Angeli CD. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil. Arch. Ophthalmol. 115(12), 1600–1601 (1997).
- Yamamoto N, Ohmura T, Suzuki H, Shirasawa H. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology 109(2), 249–252 (2002).
- Di Pascuale MA, Espana EM, Tseng SC. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea 23(1), 89–92 (2004).
- Huerva V, Mateo AJ, Mangues I, Jurjo C. Short-term mitomycin C followed by long-term interferon α2β for conjunctiva–cornea intraepithelial neoplasia. Cornea 25(10), 1220–1223 (2006).
- Morrow CS, Cowan KH. Drug resistance and its clinical circumvention. In: Cancer Medicine (3rd Edition). Holland JF, Frei E III, Bast RC (Eds). Lea & Febiger, PA, USA, Vol. 1, sect. XV (1993).
- Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br. J. Ophthalmol. 82(5), 476–479 (1998).
- Frei E III, Antman KH. Combination chemotherapy, dose, and schedule. In: Cancer Medicine (3rd Edition). Holland JF, Frei E III, Bast RC (Eds). Lea & Febiger, PA, USA, Vol. 1, sect. XV (1993).
- Barbazetto IA, Lee TC, Abramson DH. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. Am. J. Ophthalmol. 138(2), 183–189 (2004).
- Pizzarello LD, Jakobiec FA. Bowen’s disease of the conjunctiva: a misnomer. In: Ocular and Adnexal Tumors. Jakobiec FA (Ed.). Aesculapius, AL, USA, 553–571 (1978).
- Cerezo L, Otero J, Aragón G et al. Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90. Radiother. Oncol. 17(3), 191–197 (1990).
- Ferry AP, Meltzer MA, Taub RN. Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva. Trans. Am. Ophthalmol. Soc. 74, 154–171 (1976).
- Danopoulos ED, Danopoulou IE, Liarikos SB, Merkuris KM. Effects of urea treatment in malignancies of the conjunctiva and cornea. Ophthalmologica 178, 198–203 (1979).
- Herbort CP, Zografos L, Zwingli M, Schoeneich M. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium. Graefes Arch. Clin. Exp. Ophthalmol. 226(1), 22–26 (1988).
- Krilis M, Tsang H, Coroneo M. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Ophthalmology 119(10), 1969–1973 (2012).
- Paul S, Stone DU. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia. J. Ocul. Pharmacol. Ther. 28(6), 647–649 (2012).
- Spadea L, Petrucci R, Balestrazzi E. excimer laser phototherapeutic keratectomy for recurrent intraepithelial corneoconjunctival carcinoma. J. Cataract Refract. Surg. 28(11), 2062–2064 (2002).
- Hodson K, Karp C. Removal of ocular surface squamous neoplasia with cryotherapy and amniotic membrane transplantation. Techniques in Ophthalmology. 9, 1–4 (2011).
- Nelson KD, McSoley JJ. Clinical findings and management of conjunctival intraepithelial neoplasia. Optometry 82(1), 15–21 (2011).
- Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv. Ophthalmol. 39(6), 429–450 (1995).
- Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 104(3), 485–492 (1997).
- Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul. Surf. 1(2), 66–73 (2003).
- Wilkes TD, Fraunfelder FT. Principles of cryosurgery. Ophthalmic Surg. 10(8), 21–30 (1979).
- Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24(4), 369–377 (2005).
- Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br. J. Ophthalmol. 86(6), 640–645 (2002).
- Zaki AA, Farid SF. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Cornea 28(9), 986–988 (2009).
- Mohammadpour M. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva. Cornea 31(4), 465 (2012).
- Galor A, Karp CL, Oellers P et al. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology 119(10), 1974–1981 (2012).
- Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 93(2), 176–183 (1986).
- Lee GA, Hirst LW. Retrospective study of ocular surface squamous neoplasia. Aust. N. Z. J. Ophthalmol. 25(4), 269–276 (1997).
- Buus DR, Tse DT, Folberg R, Buuns DR. Microscopically controlled excision of conjunctival squamous cell carcinoma. Am. J. Ophthalmol. 117(1), 97–102 (1994).